title: Breast cancer brain metastases: new directions in systemic therapy.
abstract: The management of patients with brain metastases from breast cancer continues to be a major clinical challenge. The standard initial therapeutic approach depends upon the size, location, and number of metastatic lesions and includes consideration of surgical resection, whole-brain radiotherapy, and stereotactic radiosurgery. As systemic therapies for control of extracranial disease improve, patients are surviving long enough to experience subsequent progression events in the brain. Therefore, there is an increasing need to identify both more effective initial treatments as well as to develop multiple lines of salvage treatments for patients with breast cancer brain metastases. This review summarises the clinical experience to date with respect to cytotoxic and targeted systemic therapies for the treatment of brain metastases, highlights ongoing and planned trials of novel approaches and identifies potential targets for future investigation.
authors: Dana-Farber Cancer Institute, Boston, MA, USA.
authors: Nancy U
authors: NU
authors: Lin
keywords: brain and nervous system; breast
references: Breast Cancer Res Treat. 2012 Jun;133(3):1057-65
references: 22418700
references: Clin Med Insights Oncol. 2011;5:117-29
references: 21603247
references: J Clin Oncol. 2010 Dec 1;28(34):5110-5
references: 20975068
references: Paediatr Drugs. 2012 Feb 1;14(1):51-60
references: 22136276
references: Breast Cancer Res Treat. 2010 Aug;123(1):125-8
references: 19916047
references: Cancer. 1992 Feb 15;69(4):972-80
references: 1735089
references: Clin Cancer Res. 1999 Nov;5(11):3394-402
references: 10589750
references: J Clin Oncol. 2008 Apr 20;26(12):1993-9
references: 18421051
references: Cancer. 2006 Sep 15;107(6):1348-54
references: 16909414
references: Br J Cancer. 2010 Mar 16;102(6):995-1002
references: 20179708
references: Cancer. 1981 Jul 15;48(2):384-94
references: 7237407
references: Br J Pharmacol. 2008 Sep;155(2):185-97
references: 18574456
references: Neuro Oncol. 2009 Apr;11(2):158-66
references: 18780814
references: J Clin Oncol. 2000 Jun;18(11):2349-51
references: 10829059
references: J Neurooncol. 2011 Sep;104(2):545-51
references: 21274592
references: Lancet Oncol. 2009 Nov;10(11):1037-44
references: 19801201
references: Ann Oncol. 2006 Jun;17(6):952-6
references: 16565212
references: Ann Oncol. 2011 Mar;22(3):625-630
references: 20724575
references: J Clin Oncol. 2007 Oct 20;25(30):4722-9
references: 17947719
references: Lancet Oncol. 2006 Nov;7(11):888
references: 17081914
references: Cancer. 2008 Jun;112(11):2359-67
references: 18361426
references: Cancer. 2007 Dec 15;110(12):2640-7
references: 17960791
references: Clin Cancer Res. 2009 Oct 1;15(19):6148-57
references: 19789319
references: J Surg Oncol. 1991 Sep;48(1):28-33
references: 1653879
references: Clin Cancer Res. 2010 Jan 1;16(1):269-78
references: 20028762
references: J Neurooncol. 2008 Jul;88(3):359-65
references: 18398574
references: Cancer. 1982 Feb 15;49(4):759-72
references: 6895713
references: Cancer Chemother Pharmacol. 2000;46(1):19-26
references: 10912573
references: Br J Cancer. 2001 Jan;84(2):157-63
references: 11161370
references: Clin Cancer Res. 2009 Feb 15;15(4):1452-9
references: 19228746
references: Radiology. 2007 Dec;245(3):824-30
references: 17954616
references: Mol Cancer Ther. 2012 Feb;11(2):308-16
references: 22203732
references: Cancer. 2001 Nov 15;92(10):2517-22
references: 11745184
references: J Neurooncol. 2010 Nov;100(2):261-8
references: 20449631
references: J Clin Oncol. 2012 Feb 1;30(4):419-25
references: 22203767
references: Breast Cancer Res Treat. 2000 Aug;62(3):211-6
references: 11072785
references: J Neurooncol. 1995;24(3):299-301
references: 7595761
references: Clin Exp Metastasis. 2004;21(2):107-18
references: 15168728
references: Breast Cancer Res. 2012 Oct 01;14(5):R129
references: 23025714
references: Breast Cancer Res Treat. 2012 Jul;134(1):333-43
references: 22538770
references: Cancer. 2011 Apr 15;117(8):1602-11
references: 21472708
references: Breast Cancer Res. 2008;10(1):R20
references: 18307763
references: Lancet Oncol. 2006 Sep;7(9):778-80
references: 16945774
references: Clin Breast Cancer. 2006 Jun;7(2):164-6
references: 16800978
references: J Clin Oncol. 2012 Aug 1;30(22):2718-24
references: 22565002
references: Anticancer Drugs. 2008 Sep;19(8):832-6
references: 18690096
references: J Clin Oncol. 2011 Aug 10;29(23):3126-32
references: 21730275
references: Pharm Res. 2009 Nov;26(11):2486-94
references: 19774344
references: Breast. 2006 Jun;15(3):440-2
references: 16169225
references: J Neurooncol. 2006 Jul;78(3):255-60
references: 16344918
references: J Clin Oncol. 2012 Jan 20;30(3):282-90
references: 22162589
references: Ann Oncol. 2006 Jun;17(6):935-44
references: 16603601
references: J Neurooncol. 2008 Mar;87(1):85-90
references: 17987262
references: J Clin Oncol. 2010 Mar 10;28(8):1301-7
references: 20142587
references: Clin Breast Cancer. 2011 Dec;11(6):376-83
references: 21697017
references: J Clin Oncol. 2010 Jul 10;28(20):3271-7
references: 20498394
references: Cancer. 2008 Nov 15;113(10):2638-45
references: 18833576
references: N Engl J Med. 2012 Jan 12;366(2):109-19
references: 22149875
references: Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2111-7
references: 21497451
references: J Neurooncol. 2011 Dec;105(3):613-20
references: 21706359
references: Mol Cancer Ther. 2011 Jun;10(6):1093-101
references: 21490305
references: Cancer. 2011 Jul 15;117(14):3093-100
references: 21264845
references: Mol Cancer Ther. 2012 Sep;11(9):1959-67
references: 22622283
references: Ann Oncol. 2008 Jul;19(7):1242-1248
references: 18334512
references: Tumori. 1993 Oct 31;79(5):359-62
references: 8116083
references: Br J Cancer. 2012 Jan 31;106(3):440-6
references: 22233926
references: J Neurooncol. 2005 Jan;71(1):61-5
references: 15719277
references: Cancer. 2012 Nov 15;118(22):5463-72
references: 22544643
references: J Clin Oncol. 2012 Feb 1;30(4):372-9
references: 22203755
references: J Neurooncol. 2010 Jan;96(1):1-5
references: 19957010
references: Clin Cancer Res. 2011 Jul 15;17(14):4834-43
references: 21768129
references: Cancer. 1999 Apr 1;85(7):1599-605
references: 10193952
references: Oncol Rep. 2006 May;15(5):1373-7
references: 16596213
references: J Clin Oncol. 2004 Jul 15;22(14):2865-72
references: 15254054
references: Clin Exp Metastasis. 2011 Dec;28(8):899-908
references: 21953073
references: J Neurooncol. 2012 Oct;110(1):27-36
references: 22842979
references: Neurology. 2005 May 10;64(9):1625-7
references: 15883329
references: Breast Cancer Res Treat. 2011 Oct;129(3):809-17
references: 21785952
references: J Natl Cancer Inst. 2003 Oct 1;95(19):1482-5
references: 14519755
references: J Neurooncol. 2007 Nov;85(2):223-7
references: 17611719
references: Jpn J Clin Oncol. 2003 May;33(5):229-31
references: 12865466
references: Clin Cancer Res. 2011 Jan 1;17(1):142-53
references: 21081656
references: Cancer. 2010 Sep 15;116(18):4238-47
references: 20549816
references: N Engl J Med. 2012 Feb 9;366(6):520-9
references: 22149876
references: Cancer. 2003 Jun 15;97(12):2972-7
references: 12784331
references: J Clin Oncol. 2010 Jun 1;28(16):2698-704
references: 20421541
references: J Clin Oncol. 2010 Apr 10;28(11):1963-72
references: 20231676
references: Breast Cancer Res Treat. 2012 Nov;136(1):153-60
references: 22968656